Cargando…

Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis

OBJECTIVE: To compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes. DESIGN: Systematic review and network meta-analysis. DATA SOURCES: Medline, Cochrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hodkinson, Alexander, Tsimpida, Dialechti, Kontopantelis, Evangelos, Rutter, Martin K, Mamas, Mamas A, Panagioti, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943592/ https://www.ncbi.nlm.nih.gov/pubmed/35331984 http://dx.doi.org/10.1136/bmj-2021-067731

Ejemplares similares

Comparison of Self-reported Measures of Hearing With an Objective Audiometric Measure in Adults in the English Longitudinal Study of Ageing
por: Tsimpida, Dialechti, et al.
Publicado: (2020)

Socioeconomic and lifestyle factors associated with hearing loss in older adults: a cross-sectional study of the English Longitudinal Study of Ageing (ELSA)
por: Tsimpida, Dialechti, et al.
Publicado: (2019)

Regional patterns and trends of hearing loss in England: evidence from the English longitudinal study of ageing (ELSA) and implications for health policy
por: Tsimpida, Dialechti, et al.
Publicado: (2020)

The dynamic relationship between hearing loss, quality of life, socioeconomic position and depression and the impact of hearing aids: answers from the English Longitudinal Study of Ageing (ELSA)
por: Tsimpida, Dialechti, et al.
Publicado: (2021)

Conceptual Model of Hearing Health Inequalities (HHI Model): A Critical Interpretive Synthesis
por: Tsimpida, Dialechti, et al.
Publicado: (2021)

Of statins and low-density lipoprotein cholesterol, “fats” and fiction
por: Unnikrishnan, Ambika Gopalakrishnan, et al.
Publicado: (2016)

Temporal trends of hospitalizations, comorbidity burden and in-hospital outcomes in patients admitted with asthma in the United States: Population-based study
por: Zghebi, Salwa S., et al.
Publicado: (2022)

Excess mortality in England and Wales during the first wave of the COVID-19 pandemic
por: Kontopantelis, Evangelos, et al.
Publicado: (2021)

Endothelial progenitor cells: Exploring the pleiotropic effects of statins
por: Sandhu, Kully, et al.
Publicado: (2017)

Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
por: Hodkinson, Alexander, et al.
Publicado: (2021)

Self‐Reported Sleep Duration and Quality and Cardiovascular Disease and Mortality: A Dose‐Response Meta‐Analysis
por: Kwok, Chun Shing, et al.
Publicado: (2018)

Self-management interventions to reduce healthcare use and improve quality of life among patients with asthma: systematic review and network meta-analysis
por: Hodkinson, Alexander, et al.
Publicado: (2020)

Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
por: Li, Yi-Heng, et al.
Publicado: (2020)

Determining propensity for sub-optimal low-density lipoprotein cholesterol response to statins and future risk of cardiovascular disease
por: Weng, Stephen Franklin, et al.
Publicado: (2021)

Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

Familial Resemblance in Low‐Density Lipoprotein Cholesterol Response to Statins in the Danish Population
por: Corn, Giulia, et al.
Publicado: (2022)

Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study
por: Zhao, Yuqi, et al.
Publicado: (2023)

Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
por: Sun, Haixia, et al.
Publicado: (2015)

Disparities in mortality among 25–44-year-olds in England: a longitudinal, population-based study
por: Kontopantelis, Evangelos, et al.
Publicado: (2018)

Incidence of nonvalvular atrial fibrillation and oral anticoagulant prescribing in England, 2009 to 2019: A cohort study
por: Ajabnoor, Alyaa M., et al.
Publicado: (2022)

The Achievement of Non-high-density Lipoprotein Cholesterol Target in Patients with Very High Atherosclerotic Cardiovascular Disease Risk Stratified by Triglyceride Levels Despite Statin-controlled Low-density Lipoprotein Cholesterol
por: Al-Sabti, Hilal, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

Determinants of health- related quality of life (HRQoL) among deaf and hard of hearing adults in Greece: a cross-sectional study
por: Tsimpida, Dialechti, et al.
Publicado: (2018)

Comorbidity clusters and in-hospital outcomes in patients admitted with acute myocardial infarction in the USA: A national population-based study
por: Zghebi, Salwa S., et al.
Publicado: (2023)

Increasing socioeconomic gap between the young and old: temporal trends in health and overall deprivation in England by age, sex, urbanity and ethnicity, 2004–2015
por: Kontopantelis, Evangelos, et al.
Publicado: (2018)

Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low‐Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients
por: Okerson, Ted, et al.
Publicado: (2017)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

High-density lipoprotein cholesterol as a predictor of clinical outcomes in patients achieving low-density lipoprotein cholesterol targets with statins after percutaneous coronary intervention
por: Seo, Suk Min, et al.
Publicado: (2011)

Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins
por: Sonoda, Takeshi, et al.
Publicado: (2018)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Low Levels of Low-Density Lipoprotein Cholesterol and Mortality Outcomes in Non-Statin Users
por: Sung, Ki-Chul, et al.
Publicado: (2019)

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)

Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome
por: Im, Jihaeng, et al.
Publicado: (2021)

Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy
por: Hyun, Myung Han, et al.
Publicado: (2019)

Assessment of Sex Disparities in Nonacceptance of Statin Therapy and Low-Density Lipoprotein Cholesterol Levels Among Patients at High Cardiovascular Risk
por: Brown, C. Justin, et al.
Publicado: (2023)

Chronic morbidity, deprivation and primary medical care spending in England in 2015-16: a cross-sectional spatial analysis
por: Kontopantelis, Evangelos, et al.
Publicado: (2018)

Temporal trends in relative survival following percutaneous coronary intervention
por: Hulme, William J, et al.
Publicado: (2019)

Network Meta‐Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid‐Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low‐Density Lipoprotein Cholesterol
por: Toth, Peter P., et al.
Publicado: (2022)

Effect of Ezetimibe Added to High-Intensity Statin Therapy on Low-Density Lipoprotein Cholesterol Levels: A Meta-Analysis
por: Lee, Jayden, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cktt19s5hc5tr4emqdi7frit0f